|
There are many effective off-patent drugs whose pharmacology and safety is well documented.
Opal uses its formulation & development expertise as well as technological innovation to
differentiate and add value to established generic injectables. Harnessing the industry’s
over-capacity and working in partnership, Opal is able to overcome complex manufacturing
challenges or supply novel preparations into niche, low volume, and high value specialist markets.
In the longer term the business will be expanded into “New Generics” with “New Technologies” in a variety of therapeutic areas. Its wide range of commercial projects will allow Opal to adapt to a changing healthcare market. |